Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio-Reference Laboratories Inc (NASDAQ:BRLI)

44.37
Delayed Data
As of Jul 31
 -0.12 / -0.27%
Today’s Change
26.32
Today|||52-Week Range
47.49
+38.10%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$1.3B

Company Description

Bio-Reference Laboratories, Inc. provides clinical laboratory testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. It offers a comprehensive list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology, services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology and other tissue analysis. The company primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. It also offers laboratory services to physician offices in the areas with an infrastructure that includes a comprehensive logistical department, extensive phlebotomy services and phlebotomy draw stations scattered around its geographic area. Bio-Reference Laboratories was founded by Marc D. Grodman on December 24, 1981 and is headquartered in Elmwood Park, NJ.

Contact Information

Bio-Reference Laboratories, Inc.
481 Edward H. Ross Drive
Elmwood Park New Jersey 07407
P:(201) 791-2600
Investor Relations:

Employees

Shareholders

Other institutional40.87%
Mutual fund holders34.33%
Individual stakeholders15.19%

Top Executives

Marc D. GrodmanChairman, President & Chief Executive Officer
Howard DubinettChief Operating Officer, Director & Executive VP
Nicholas PapazicosChief Financial Officer
Richard L. FahertyChief Information Officer
James WeisbergerChief Medical Officer, SVP & Laboratory Director